Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01182519 · ClinicalTrials.gov registry record
Lung Inflammation and Lung Metastases From Breast Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 400
- Enrollment target
NCT01182519: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01182519 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01182519 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if there is a link between cigarette smoking, inflammation and the spread of breast cancer to the lung. We think that women who are current or former smokers may be at increased risk for breast cancer spreading to the lung compared to women who have never smoked. Smoking causes inflammation in the lung in some women. Researchers at Memorial Sloan-Kettering (MSKCC) think that smoking-related lung inflammation may increase the chance of breast cancer spreading to the lung. In order to find out whether inflammation plays a role in breast cancer spreading to the lung, we will measure a urinary marker of lung inflammation. This will allow us to determine if this marker is more commonly elevated in women with breast cancer that has spread to the lung compared to those without breast cancer in the lung. We will also collect DNA from blood to have the opportunity to determine if there are differences in DNA in women with or without breast cancer that has spread to the other sites including the lung. We will also collect blood to determine if we can identify risk factors for the spread of breast cancer to the lungs.
Interventions
- BEHAVIORAL questionnaire, blood draw and urine sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2010-08 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01182519
The ClinicalTrials.gov registry entry for NCT01182519 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaire, blood draw and urine sample is the first listed.
NCT01182519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01182519 about?
NCT01182519 is a clinical study titled "Lung Inflammation and Lung Metastases From Breast Cancer". The purpose of this study is to find out if there is a link between cigarette smoking, inflammation and the spread of breast cancer to the lung. We think that women who are current or former smokers may be at increased risk for breast cancer spreading to the lung compared to women who have never smo...
What is the current status of trial NCT01182519?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2010-08. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01182519?
The interventions under investigation include: questionnaire, blood draw and urine sample (BEHAVIORAL).
Who is sponsoring clinical trial NCT01182519?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.